Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;41(1):145-152.
doi: 10.5851/kosfa.2020.e78. Epub 2021 Jan 1.

Bioconversion Products of Whey by Lactic Acid Bacteria Exert Anti-Adipogenic Effect

Affiliations
Review

Bioconversion Products of Whey by Lactic Acid Bacteria Exert Anti-Adipogenic Effect

Ji Soo Lee et al. Food Sci Anim Resour. 2021 Jan.

Abstract

Microbial bioconversion using lactic acid bacteria (LAB) provides several human health benefits. Although whey and whey-derived bioactive compounds can contribute to an improvement in human health, the potential anti-obesity effect of whey bioconversion by LAB has not been well studied. This study aimed to investigate whether bioconversion of whey by Pediococcus pentosaceus KI31 and Lactobacillus sakei KI36 (KI31-W and KI36-W, respectively) inhibits 3T3-L1 preadipocyte differentiation. Both KI31-W and KI36-W reduced intracellular lipid accumulation significantly, without decreasing 3T3-L1 preadipocyte proliferation. In addition, obesity-related transcription factor (peroxisome proliferator-activated receptor γ) and genes (adipocyte fatty acid-binding protein and lipoprotein lipase) were down-regulated significantly in 3T3-L1 cells in the presence of KI31-W and KI36-W. Collectively, these results suggest that bioconversion of whey by LAB exhibits anti-adipogenic activity and may be applied as a therapeutic agent for obesity.

Keywords: 3T3-L1 preadipocyte; bioconversion; lactic acid bacteria; obesity; whey.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest.

Figures

Fig. 1.
Fig. 1.. Cell viability of 3T3-L1 adipocytes in the presence of KI 31-W and KI 36-W.
The cell viability was determined by MTT assay after 3T3-L1 cells were treated with KI 31-W or KI 36-W for 24 h. The results were obtained from three independent experiments.
Fig. 2.
Fig. 2.. Effect of KI 31-W and KI 36-W on lipid accumulation in 3T3-L1 adipocytes.
Determination of lipid content by Oil Red O staining in fully differentiated 3T3-L1 adipocytes treated with KI 31-W (A) or KI 36-W (B). Images represent microscopy of Oil Red O-stained cells. The results were obtained from three independent experiments. (C) lipid accumulation in 3T3-L1 cells in the presence of non-bioconverted whey was determined by Oil Red O staining. (D) protein profiles of non-bioconverted and bioconversion of whey were analyzed by SDS-PAGE. M, size marker.
Fig. 3.
Fig. 3.. Effect of KI 31-W and KI 36-W on the mRNA levels of adipogenesis- and lipogenesis-related genes in 3T3-L1 adipocytes.
The mRNA expression of PPARγ, aP2, and LPL in 3T3-L1 adipocytes in the presence of KI 31-W or KI 36-W were quantified by real-time RT-PCR analysis. The results were obtained from three independent experiments. PPARγ, peroxisome proliferator-activated receptor.

References

    1. Asha S, Vidyavathi M. Cunninghamella--a microbial model for drug metabolism studies: A review. Biotechnol Adv. 2009;27:16–29. doi: 10.1016/j.biotechadv.2008.07.005. - DOI - PubMed
    1. Bjørnshave A, Hermansen K. Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes. Rev Diabet Stud. 2014;11:153–166. doi: 10.1900/RDS.2014.11.153. - DOI - PMC - PubMed
    1. Boguta AM, Bringel F, Martinussen J, Jensen PR. Screening of lactic acid bacteria for their potential as microbial cell factories for bioconversion of lignocellulosic feedstocks. Microb Cell Fact. 2014;13:97. doi: 10.1186/s12934-014-0097-0. - DOI - PMC - PubMed
    1. Cho H, Lee A, Kim K. The effect of serum types on chondrogenic differentiation of adipose-derived stem cells. Biomater Res. 2018;22:6. doi: 10.1186/s40824-018-0116-z. - DOI - PMC - PubMed
    1. Domingues L, Dantas MM, Lima N, Teixeira JA. Continuous ethanol fermentation of lactose by a recombinant flocculating Saccharomyces cerevisiae strain. Biotechnol Bioeng. 1999;64:692–697. doi: 10.1002/(SICI)1097-0290(19990920)64:6<692::AID-BIT8>3.0.CO;2-J. - DOI - PubMed